6.900
+9,52%
2026-10-08
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +162.1% | +18.3% | 1 / 3 | +5.4% | +11.69 pp | +4.94 pp | +1.2% | 0.00 | 58.34 | 12,0 | +5,4% | 1,0 | +162,1% | 58.34 | 17.39 | +235,5% |
| Pts | 12 | 0 | 4 | 0 | 12 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 6.900 (close price on 2026-10-08)EPS (TTM): 118,3
Financial charts
1.Revenue & growth
VND bn12,0Q2/26
1.Revenue & growth
VND bn12,0Q2/26
2.Profit & growth
VND bn0,99Q2/26
3.Profit mix (Penman)
VND bn2,56Q2/26
4.Margins & cost structure
%34.2%Q2/26
5.Returns & cash cycle
% · days1.5%Q2/26
6.Earnings quality & cash
VND bn0,87Q2/26
7.Asset structure
VND bn242Q2/26
8.Funding & debt health
VND bn · times242Q2/26
9.Revenue backlog
VND bn0,76Q2/26
10.Valuation
times · %58,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %66Q2/26
Adjusted EPS growth, latest quarter
162%
Average adjusted EPS growth, 3 quarters
58.5%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26